Liberty Health Sciences provides investors with access to the growing United States cannabis market. Our investor-focused approach helps ensure we minimize risk and maximize returns for our shareholders.



Our stringent investment criteria for acquisition targets in new states reduces investor risk and aims to maximize shareholder value.

Liberty will prioritize investment in states that meet the following conditions:

Robust State Legislation in Place

Long List of Qualifying Conditions

No Canopy Restrictions

Large Population of Users


stock quote


asked questions

Liberty’s financial statements will be published on our website quarterly.

Liberty trades on the Canadian Securities Exchange under LHS. Shares can be purchased through an investment broker or an online trading platform. Shares cannot be purchased directly from the company.

To date, Liberty has entered into an exclusive Management Agreement with Chestnut Hill Tree Farm LLC (“Chestnut”), a Florida nursery authorized by the Florida Department of Health, Office of Compassionate Use, as a dispensing organization of medical cannabis to patients in need in the State of Florida. Chestnut holds one of eight licenses granted in Florida, which currently represents approximately 14% of the U.S. medical cannabis market with a total estimated market size at maturity of over $1.1 billion.

Liberty Health Sciences was launched to acquire and operate U.S. – based companies in the medical cannabis market. Liberty adds value to acquired companies through our proven expertise in commercial scale greenhouse growing at a low cost, our proprietary Seed-to- Sale Certified process, and our proprietary automation and processing methods.

Load More